Gout medication treatment patterns and adherence to standards of care from a managed care perspective

…, PA Patel, HR Schumacher, KG Saag, AW Bakst - Mayo Clinic …, 2006 - Elsevier
OBJECTIVE To determine allopurinol treatment patterns and adherence to published
standards of care for patients with gout. PATIENTS AND METHODS This retrospective claims …

The progressive cost of complications in type 2 diabetes mellitus

JB Brown, KL Pedula, AW Bakst - Archives of internal medicine, 1999 - jamanetwork.com
Background A substantial proportion of the costs of diabetes treatment arises from treating
long-term complications, particularly cardiovascular and renal disease. However, little is …

Proton pump inhibitor utilization patterns in infants

JJ Barron, H Tan, J Spalding, AW Bakst… - Journal of pediatric …, 2007 - journals.lww.com
Objective: Practice patterns regarding pediatric gastroesophageal reflux disease include
acid suppression for infants meeting certain clinical criteria. This study aimed to examine the …

Serum urate levels and gout flares: analysis from managed care data

…, W Yang, KK Brewer, AW Bakst - JCR: Journal of …, 2006 - journals.lww.com
Background: The desired serum urate level (SUA) for prevention of gout attacks is widely
recommended to be in the subsaturating range,< 6.0 mg/dL. Objectives: The objectives of this …

American translation, modification, and validation of the St. George's Respiratory Questionnaire

…, GE Schumacher, S Freeman, M LeMoine, AW Bakst… - Clinical …, 2000 - Elsevier
BACKGROUND: The St. George's Respiratory Questionnaire (SGRQ) is a 50-item health
status survey specific for chronic obstructive pulmonary disease (COPD) and other respiratory …

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

…, J Gubb, R Nieman, J Edelson, O Amit, A Bakst… - The Lancet, 2001 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is a common, progressive
respiratory disease that causes great morbidity and mortality despite treatment. There is …

Infection in surgical patients: effects on mortality, hospitalization, and postdischarge care

JT Dipiro, RG Martindale, A Bakst… - American journal of …, 1998 - academic.oup.com
In-hospital mortality, length of stay (LOS), and level of postdischarge care in infected and
noninfected surgical patients were studied. An analysis was conducted of a database that …

Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.

JB Brown, GA Nichols, HS Glauber, AW Bakst - Diabetes care, 1999 - Am Diabetes Assoc
OBJECTIVE: To describe and analyze the time course of medical care costs caused by type
2 diabetes, from the time of diagnosis through the first 8 postdiagnostic years. RESEARCH …

Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus

JB Brown, GA Nichols, HS Glauber, A Bakst - Clinical therapeutics, 1999 - Elsevier
Studies performed for drug registration provide little insight into the long-term use and
effectiveness of drugs in “real world” populations and settings. To obtain such insight, we used 10 …

The quality of life impact of acute exacerbations of chronic bronchitis (AECB): a literature review

JK Schmier, MT Halpern, MK Higashi, A Bakst - Quality of life research, 2005 - Springer
Background: The impact of acute exacerbations of chronic bronchitis (AECB), a common
consequence of chronic obstructive pulmonary disease (COPD), is extensive, with symptoms …